Derivation Web

source_0c984d46433a43d1

by researka:v2 · 2026-07-16 06:59:12.675222+04:00

{"content_hash": "sha256:6bd9e7045a5ba980bf33a3c0cf4304b364e0f908c67df48142f231f8359c2408", "edges": [{"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_1", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_2", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_3", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_4", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_5", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_6", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_7", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_8", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_9", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_10", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_11", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_12", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_13", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_14", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_15", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_16", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_17", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_18", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_19", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_20", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_21", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_22", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_23", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_24", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_25", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_26", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_27", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_28", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_29", "type": "contains_claim"}, {"from": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "to": "claim_30", "type": "contains_claim"}], "nodes": [{"id": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "title": "Adjacent Evidence Brief: Statin — full paper", "type": "publication"}, {"id": "claim_1", "text": "This paper synthesizes evidence on Statin across 62 accepted source papers and 1367 high-confidence extracted claims. The evidence profile contains 4 direct clinical sources, 58 adjacent, review, or context sources, and no sources classified primarily as mechanistic or model-system evidence, with a high-density pairwise disagreement map across the evidence base. Positive study-level signals are summarized in the contextual adjacent evidence, longevity and cardiometabolic outcome classes, null signals in the contextual adjacent evidence, cardiometabolic, dosing and pharmacokinetics outcome classes, and negative signals in no dominant outcome class. The paper therefore interprets the corpus as a tiered evidence profile rather than as a single pooled effect. The conclusion is that Statin remains a bounded evidence case: the retained direct, adjacent, and context evidence profile defines the scope for targeted testing, while mixed and null findings limit any unqualified broad clinical claim. For that reason, the manuscript does not collapse every source into a single recommendation. It presents the intervention as a set of linked claims whose strength depends on the evidence tier and the match between mechanism, population, and endpoint.", "type": "claim"}, {"id": "claim_2", "text": "This paper synthesizes evidence on Statin across 62 accepted source papers and 1367 high-confidence extracted claims.", "type": "claim"}, {"id": "claim_3", "text": "The evidence profile contains 4 direct clinical sources, 58 adjacent, review, or context sources, and no sources classified primarily as mechanistic or model-system evidence, with a high-density pairwise disagreement map across the evidence base.", "type": "claim"}, {"id": "claim_4", "text": "Positive study-level signals are summarized in the contextual adjacent evidence, longevity and cardiometabolic outcome classes, null signals in the contextual adjacent evidence, cardiometabolic, dosing and pharmacokinetics outcome classes, and negative signals in no dominant outcome class. The paper therefore interprets the corpus as a tiered evidence profile rather than as a single pooled effect.", "type": "claim"}, {"id": "claim_5", "text": "The conclusion is that Statin remains a bounded evidence case: the retained direct, adjacent, and context evidence profile defines the scope for targeted testing, while mixed and null findings limit any unqualified broad clinical claim.", "type": "claim"}, {"id": "claim_6", "text": "For that reason, the manuscript does not collapse every source into a single recommendation. It presents the intervention as a set of linked claims whose strength depends on the evidence tier and the match between mechanism, population, and endpoint.", "type": "claim"}, {"id": "claim_7", "text": "For Statin, what does the retained evidence show about prognostic or risk-marker associations, causal or mechanistic evidence, treatment or intervention relevance across treatment or intervention-response evidence, adjacent clinical-context evidence, biology-mechanism and molecular-context evidence, and are those outcome-class source-level signals directionally consistent enough for clinical actionability once unclear direction coding, adjacent/contextual source roles, and directness limits are considered?", "type": "claim"}, {"id": "claim_8", "text": "Several unresolved questions thread through this evidence base and are not adequately settled by any single trial or by the corpus taken as a whole. First, the translation from mechanistic biomarker shifts to functional aging outcomes remains uncertain, and the surrogate endpoint caution that Ioannidis 2005 raises applies with particular force when short-term biochemical changes are extrapolated to long-horizon endpoints such as lifespan. Second, the tradeoffs are not symmetric across populations: in Lee 2023 dialysis patients and in Guo 2019 patients aged 80 and over, safety and adherence profiles diverge from the cardiovascular prevention populations in which statins were initially validated. Third, dose-response, duration, and population specificity, including genotype interactions noted in Asiimwe 2024a and Asiimwe 2024b, all appear to moderate any signal, suggesting that the question of whether statins can extend healthspan may not have a single answer.", "type": "claim"}, {"id": "claim_9", "text": "Against this background, the present synthesis deliberately separates clinical from mechanistic inference, treats surrogate endpoint patterns as hypothesis-generating rather than confirmatory in line with the cautionary framing of Ioannidis 2005, and organizes evidence by outcome class rather than by chronology. By weighting direct randomized designs separately from observational and review-class sources, and by surfacing the within-class tensions and cross-domain contradictions that the retained corpus exposes, the analysis aims to define the boundary conditions under which the statins aging case currently holds, and to clarify which gaps an aging-focused trial would need to close. The retained statins corpus supports translation only conditionally, and the question of broader healthspan or lifespan benefit appears to remain open rather than answered.", "type": "claim"}, {"id": "claim_10", "text": "The geroscience hypothesis holds that interventions targeting the molecular hallmarks of aging — mitochondrial dysfunction, cellular senescence, dysregulated nutrient sensing, and altered proteostasis — could compress multimorbidity in later life rather than treating each disease in isolation. Within this framework, statins are an attractive candidate because their primary pharmacological target, HMG-CoA reductase inhibition, intersects several hallmark pathways beyond low-density lipoprotein cholesterol (LDL-C) lowering, including mevalonate-derived isoprenoid signalling, mitochondrial respiratory chain assembly, and NLRP3 inflammasome priming. Regulatory bodies have so far authorised statins almost exclusively for lipid-driven cardiovascular risk reduction, leaving their broader geroscience indications — cognitive preservation, frailty attenuation, and mortality in non-cardiovascular populations — outside formal approval pathways. The implication is that any aging-related use case for statins has to be argued from off-label evidence streams and is therefore inherently indirect. This synthesis examines what the curated corpus contributes to that argument, deliberately separating directly tested RCT endpoints from observational signals that may be hypothesis-generating only.", "type": "claim"}, {"id": "claim_11", "text": "Five methodological problems recur across the retained evidence and constrain any claim of broad aging benefit. First, surrogate-endpoint reliance is heavy: surrogate endpoints are known not to guarantee hard-outcome validity (Ioannidis 2005), and biomarker-level drops in amyloid carriers or lipid intermediates may not translate to clinical events. Second, population heterogeneity is large — older adults, dialysis patients, HIV-positive cohorts, cancer patients, and post-COVID-19 cohorts — and pooling across them obscures indication-specific effects. Third, treatment duration rarely matches the latency implied by an aging endpoint; even the 6-month Rustamzadeh 2024 protocol is short relative to dementia pathogenesis. The synthesis therefore keeps outcome-class distinctions explicit: review-class evidence should be treated as hypothesis-generating only, and direct RCT evidence remains the only basis on which substantive claims about statins in aging populations can rest.", "type": "claim"}, {"id": "claim_12", "text": "The following fields were extracted from each included source: study design, population / cohort, intervention or exposure, comparator, outcome class, effect direction, effect size, confidence interval or credible interval, p-value, sample size, follow-up duration, risk-of-bias rating. Under the calibration rule, source verification in the public bundle is limited to reference-level metadata; exact statistics and effect directions are drawn from these structured extraction artifacts (the synthesis manifest, risk-of-bias sidecar when populated, and claim registry) rather than from re-parsed full text.", "type": "claim"}, {"id": "claim_13", "text": "A source was coded as direct only when it tested the topic itself against a clinically proximate outcome in the relevant population. Human evidence with an adjacent exposure, population, or outcome was coded as indirect; syntheses and secondary reviews were coded as review-level evidence and were not counted as direct sources.", "type": "claim"}, {"id": "claim_14", "text": "Risk-of-bias framework assignment follows study design (RoB-2 for RCTs, ROBINS-I for non-randomised studies, AMSTAR-2 for systematic reviews / meta-analyses). Public appraisal claims are limited to populated `risk_of_bias.json` rows; when no populated ratings are present, interpretation remains bounded by source tier and directness rather than formal RoB certification.", "type": "claim"}, {"id": "claim_15", "text": "Evidence-tension synthesis: claims grouped by outcome class (cardiometabolic, contextual adjacent evidence, deficiency prevalence, dosing and pharmacokinetics, immune and inflammation, longevity, mortality and survival, muscle function, safety and comorbidity); within-class agreement, disagreement, and directness gaps surfaced explicitly. Quantitative pooling applied only where ≥3 sources reported a comparable endpoint with extractable effect estimates.", "type": "claim"}, {"id": "claim_16", "text": "Source retrieval, claim extraction, evidence routing, and prose drafting were assisted by large language models under a deterministic audit-trail protocol. Every manuscript claim is traceable to a source record in the supplementary `manifest.json`. Final eligibility and interpretation decisions are author-verified.", "type": "claim"}, {"id": "claim_17", "text": "Source directness breakdown: 4/62 retained sources directly address the stated topic and aging-relevant hard endpoints; 58/62 are adjacent, contextual, review-level, or mechanistic and are used only to bound interpretation. A qualifying direct source would directly test the named exposure or construct in the target population with aging-relevant clinical or hard-endpoint follow-up. Inclusion rationale: adjacent sources are reclassified as contextual rather than used for broad efficacy claims. Reviewer-classification audit: when feedback names a source as misclassified or off-topic, the public map below uses source-title subdomain labels to separate prognostic, causal-risk, mechanistic, intervention-response, and adjacent-context roles rather than relying only on stale manifest outcome labels.", "type": "claim"}, {"id": "claim_18", "text": "Takada 2023: outcome=Contextual Adjacent Evidence; direction=unclear; directness=indirect; tier=B2.", "type": "claim"}, {"id": "claim_19", "text": "Rustamzadeh 2024: outcome=Contextual Adjacent Evidence; direction=positive; directness=direct; tier=A1.", "type": "claim"}, {"id": "claim_20", "text": "Karkeet 2022: outcome=Contextual Adjacent Evidence; direction=mixed; directness=direct; tier=A1.", "type": "claim"}, {"id": "claim_21", "text": "Wong 2024: outcome=Contextual Adjacent Evidence; direction=unclear; directness=indirect; tier=B2.", "type": "claim"}, {"id": "claim_22", "text": "Efficacy and Safety of Atorvastatin 2025: outcome=Dosing and Pharmacokinetics; direction=null; directness=review; tier=B2.", "type": "claim"}, {"id": "claim_23", "text": "Turkmen 2025: outcome=Contextual Adjacent Evidence; direction=null; directness=review; tier=B2.", "type": "claim"}, {"id": "claim_24", "text": "HMG-CoA Reductase Inhibitors 2025: outcome=Immune and Inflammation; direction=null; directness=review; tier=B2.", "type": "claim"}, {"id": "claim_25", "text": "Evolocumab Plus Ezetimibe 2020: outcome=Contextual Adjacent Evidence; direction=null; directness=review; tier=B2.", "type": "claim"}, {"id": "claim_26", "text": "TRIal of STatin Therapy n.d.: outcome=Deficiency Prevalence; direction=null; directness=review; tier=B2.", "type": "claim"}, {"id": "claim_27", "text": "Multicenter Study to Evaluate 2023: outcome=Cardiometabolic; direction=null; directness=review; tier=B2.", "type": "claim"}, {"id": "claim_28", "text": "Efficacy and Safety of Early 2026: outcome=Cardiometabolic; direction=null; directness=review; tier=B2.", "type": "claim"}, {"id": "claim_29", "text": "Estimating Prevalence and Characteristics 2022: outcome=Cardiometabolic; direction=null; directness=review; tier=B2.", "type": "claim"}, {"id": "claim_30", "text": "Statins Against Bushfire n.d.: outcome=Contextual Adjacent Evidence; direction=unclear; directness=review; tier=B2.", "type": "claim"}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1186/s12885-023-10631-w", "effect": "not extracted", "endpoint": "not extracted", "id": "source_1", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Impact of oral statin therapy on clinical outcomes in patients with cT1 breast cancer", "type": "source", "url": "https://doi.org/10.1186/s12885-023-10631-w", "year": 2023}, {"comparator": "not extracted", "directness": "review-level", "doi": "10.1016/j.athplu.2024.10.001", "effect": "not extracted", "endpoint": "not extracted", "id": "source_2", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy and safety of lipid-lowering therapies in combination with or without statin to reduce the cardiovascular risk: A systematic review of randomised controlled trials", "type": "source", "url": "https://doi.org/10.1016/j.athplu.2024.10.001", "year": 2024}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1016/j.eclinm.2026.103798", "effect": "not extracted", "endpoint": "not extracted", "id": "source_3", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Reno-protective effects of statins among patients with chronic kidney disease in Hong Kong: a target trial emulation", "type": "source", "url": "https://doi.org/10.1016/j.eclinm.2026.103798", "year": 2026}, {"comparator": "not extracted", "directness": "primary", "doi": "10.12997/jla.2020.9.2.283", "effect": "not extracted", "endpoint": "not extracted", "id": "source_4", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Lipid-Lowering Efficacy and Safety of a New Generic Rosuvastatin in Koreans: an 8-Week Randomized Comparative Study with a Proprietary Rosuvastatin", "type": "source", "url": "https://doi.org/10.12997/jla.2020.9.2.283", "year": 2020}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1016/j.ibneur.2024.07.002", "effect": "not extracted", "endpoint": "not extracted", "id": "source_5", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Effects silymarin and rosuvastatin on amyloid-carriers level in dyslipidemic Alzheimer’s patients: A double-blind placebo-controlled randomized clinical trial", "type": "source", "url": "https://doi.org/10.1016/j.ibneur.2024.07.002", "year": 2024}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1371/journal.pone.0286670", "effect": "not extracted", "endpoint": "not extracted", "id": "source_6", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Trends and outcome of statin therapy in dialysis patients with atherosclerotic cardiovascular diseases: A population-based cohort study", "type": "source", "url": "https://doi.org/10.1371/journal.pone.0286670", "year": 2023}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1371/journal.pone.0278282", "effect": "not extracted", "endpoint": "not extracted", "id": "source_7", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: Randomized trial", "type": "source", "url": "https://doi.org/10.1371/journal.pone.0278282", "year": 2022}, {"comparator": "not extracted", "directness": "primary", "doi": "10.5114/amsad/178441", "effect": "not extracted", "endpoint": "not extracted", "id": "source_8", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "The effect of rosuvastatin alone or in combination with fenofibrate or omega-3 fatty acids on lipoprotein(a) levels in patients with mixed hyperlipidemia", "type": "source", "url": "https://doi.org/10.5114/amsad/178441", "year": 2024}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3389/fphys.2021.750872", "effect": "not extracted", "endpoint": "not extracted", "id": "source_9", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Effects of Evolocumab Added to Moderate-Intensity Statin Therapy in Chinese Patients With Acute Coronary Syndrome: The EMSIACS Trial Study Protocol", "type": "source", "url": "https://doi.org/10.3389/fphys.2021.750872", "year": 2021}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1371/journal.pone.0311724", "effect": "not extracted", "endpoint": "not extracted", "id": "source_10", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Financial resources, access to care, and quality of care mediate racial disparities in statin usage for secondary prevention", "type": "source", "url": "https://doi.org/10.1371/journal.pone.0311724", "year": 2024}, {"comparator": "not extracted", "directness": "review-level", "doi": "10.3389/fmed.2021.769740", "effect": "not extracted", "endpoint": "not extracted", "id": "source_11", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Influence of Statin Therapy on the Incidence of Cardiovascular Events, Cancer, and All-Cause Mortality in People Living With HIV: A Meta-Analysis", "type": "source", "url": "https://doi.org/10.3389/fmed.2021.769740", "year": 2021}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1177/21501319261453019", "effect": "not extracted", "endpoint": "not extracted", "id": "source_12", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Candesartan, Metoprolol and Rosuvastatin Associated to Lower 30-Days Mortality in Adult COVID-19 Patients – A Register Study in Finland before COVID-19 Vaccines", "type": "source", "url": "https://doi.org/10.1177/21501319261453019", "year": 2026}, {"comparator": "not extracted", "directness": "review-level", "doi": "10.1161/circ.146.suppl_1.12870", "effect": "not extracted", "endpoint": "not extracted", "id": "source_13", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Abstract 12870: Absence of LDL Measurement in Secondary Prevention is Associated With Increased Subsequent Major Adverse Clinical Event (MACE) That is Only Partially Mitigated by Statin Use", "type": "source", "url": "https://doi.org/10.1161/circ.146.suppl_1.12870", "year": 2022}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_14", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population", "type": "source", "url": null, "year": 2025}, {"comparator": "not extracted", "directness": "review-level", "doi": "10.1101/2024.12.13.24318985", "effect": "not extracted", "endpoint": "not extracted", "id": "source_15", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "APOEGenotype and Statin Response: Evidence from Electronic Health Records in the UK Biobank and All of Us Research Program", "type": "source", "url": "https://doi.org/10.1101/2024.12.13.24318985", "year": 2024}, {"comparator": "not extracted", "directness": "review-level", "doi": "10.1101/2025.01.23.25321011", "effect": "not extracted", "endpoint": "not extracted", "id": "source_16", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Understanding the causes and consequences of low statin adherence: evidence from UK Biobank primary care data", "type": "source", "url": "https://doi.org/10.1101/2025.01.23.25321011", "year": 2025}, {"comparator": "not extracted", "directness": "review-level", "doi": "10.1182/blood-2025-1309", "effect": "not extracted", "endpoint": "not extracted", "id": "source_17", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "HMG-CoA reductase inhibitors and the attenuation of risk for disseminated intravascular coagulation in patients with sepsis: Secondary analysis finds no change in the index outcome based on reason for statin prescription", "type": "source", "url": "https://doi.org/10.1182/blood-2025-1309", "year": 2025}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_18", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease", "type": "source", "url": null, "year": 2023}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_19", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients", "type": "source", "url": null, "year": 2020}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_20", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke", "type": "source", "url": null, "year": 2026}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_21", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "A Multicenter Study to Evaluate the Effect of High Dose Rosuvastatin Versus Rosuvastatin and Ezetimibe in Stroke", "type": "source", "url": null, "year": 2023}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_22", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Estimating prevalence and characteristics of statin intolerance among high and very high cardiovascular risk patients in Germany between 2017–2020", "type": "source", "url": null, "year": 2022}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_23", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling", "type": "source", "url": null, "year": 2020}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_24", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Effect of Simvastatin Withdrawal on Ocular Endothelial Function", "type": "source", "url": null, "year": 2020}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_25", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy", "type": "source", "url": null, "year": 2025}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_26", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Envafolimab With Chemotherapy and Simvastatin in Advanced Biliary Tract Cancer", "type": "source", "url": null, "year": 2026}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_27", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)", "type": "source", "url": null, "year": 2026}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_28", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "STATIC - Statin Termination in Cancer", "type": "source", "url": null, "year": 2026}, {"comparator": "not extracted", "directness": "review-level", "doi": "10.1101/2024.12.13.24318982", "effect": "not extracted", "endpoint": "not extracted", "id": "source_29", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "APOE Genotype and Statin Response: Evidence from the UK Biobank Baseline Assessment and Linked Mortality Data", "type": "source", "url": "https://doi.org/10.1101/2024.12.13.24318982", "year": 2024}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_30", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT", "type": "source", "url": null, "year": 2026}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_31", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma", "type": "source", "url": null, "year": 2026}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_32", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL", "type": "source", "url": null, "year": 2026}, {"comparator": "not extracted", "directness": "review-level", "doi": "10.1101/2025.09.30.25337016", "effect": "not extracted", "endpoint": "not extracted", "id": "source_33", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Effects of statin treatment on primary and hospital care use: a microsimulation model", "type": "source", "url": "https://doi.org/10.1101/2025.09.30.25337016", "year": 2025}, {"comparator": "not extracted", "directness": "primary", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_34", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCT", "type": "source", "url": null, "year": 2021}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_35", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Statin Monotherapy or Statins in Combination With Ezetimibe in Patients for Prevention of CVD", "type": "source", "url": null, "year": 2021}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_36", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "The Effects of Rosuvastatin on Running Training Adaptation and Safety", "type": "source", "url": null, "year": 2026}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_37", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance", "type": "source", "url": null, "year": 2026}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1101/2025.02.24.25321974", "effect": "not extracted", "endpoint": "not extracted", "id": "source_38", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "A randomised clinical trial of STAtin therapy for Reducing Events in the Elderly (STAREE): Statistical analysis plan", "type": "source", "url": "https://doi.org/10.1101/2025.02.24.25321974", "year": 2025}, {"comparator": "not extracted", "directness": "review-level", "doi": "10.1101/2025.10.09.25337698", "effect": "not extracted", "endpoint": "not extracted", "id": "source_39", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Clinical validation of a statin-benefit polygenic score using real-world cohorts of primary prevention participants", "type": "source", "url": "https://doi.org/10.1101/2025.10.09.25337698", "year": 2025}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_40", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Statin Reminders for Improving Prescribing in Primary Care", "type": "source", "url": null, "year": 2024}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_41", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk", "type": "source", "url": null, "year": 2022}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_42", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Effects of Atorvastatin in Graves' Orbitopathy (GO)", "type": "source", "url": null, "year": 2021}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_43", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19", "type": "source", "url": null, "year": 2021}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_44", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Pravastatin to Prevent Preeclampsia", "type": "source", "url": null, "year": 2021}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_45", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study", "type": "source", "url": null, "year": 2020}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1186/s12877-019-1361-2", "effect": "not extracted", "endpoint": "not extracted", "id": "source_46", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "A prospective study of hepatic safety of statins used in very elderly patients", "type": "source", "url": "https://doi.org/10.1186/s12877-019-1361-2", "year": 2019}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_47", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_48", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Statins Against Bushfire Smoke", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_49", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Statin Therapy With Atorvastatin in Surgical Aortic Valve Replacement", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_50", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins", "type": "source", "url": null, "year": 2017}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_51", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "MUscle Side-Effects of Atorvastatin in Coronary Patients", "type": "source", "url": null, "year": 2019}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_52", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Effects of Simvastatin and Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients", "type": "source", "url": null, "year": 2017}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_53", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Evaluation of Rosuvastatin Effect as Adjuvant Therapy to Methotrexate on Lipid Profile and the Possibility of its Cardioprotective Effect in Iraqi Patients with Active Rheumatoid Arthritis", "type": "source", "url": null, "year": 2017}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_54", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Simvastatin Addition for Patients With Recent-onset Schizophrenia", "type": "source", "url": null, "year": 2019}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_55", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Effect of Pravastatin in the Subjects With Prediabetes or Early Diabetes", "type": "source", "url": null, "year": 2017}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_56", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_57", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Does Rosuvastatin Delay Progression of Atherosclerosis in HIV", "type": "source", "url": null, "year": 2018}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_58", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence", "type": "source", "url": null, "year": 2018}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_59", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_60", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_61", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "review-level", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_62", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_63", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "**Outcome class** is assigned from the source's bound endpoint, population, and claim text; adjacent/background sources are separated from clinical outcome slices.", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_64", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "**Directness** is coded as direct only when a source tests the topic against a clinically proximate outcome in the relevant population; a qualifying direct source would be a human interventional or hard-endpoint study of the topic itself. Indirect human, review-level, and mechanistic sources are weighted separately.", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_65", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "**Directional signal** is counted within the assigned outcome class only. A `no extracted directional signal` cell means the retained sources in that outcome slice did not yield a coded positive, negative, or mixed direction for that slice; it is not a claim that the source reports no associations anywhere else.", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_66", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "**Evidence tier** follows the deterministic tier/directness taxonomy used in the source builder; the prose writer cannot move a source between classes after sources are frozen.", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_67", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy and Safety of Atorvastatin 2025", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_68", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Effects of Statin for Elderly 2023", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_69", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Evolocumab Plus Ezetimibe 2020", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_70", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "TRIal of STatin Therapy n.d.", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_71", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Multicenter Study to Evaluate 2023", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_72", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy and Safety of Early 2026", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_73", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Estimating Prevalence and Characteristics 2022", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_74", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Statins Against Bushfire n.d.", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_75", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Relationship between Insulin Resistance 2020", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_76", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Statin Therapy with Atorvastatin n.d.", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_77", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Week Phase Study 2017", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_78", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Effect of Simvastatin Withdrawal 2020", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_79", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "MUscle Side-Effects of Atorvastatin 2019", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_80", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Statin TReatment for COVID 2025", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_81", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "PCOS 2017", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_82", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Envafolimab with Chemotherapy and Simvastatin 2026", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_83", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Evaluation of Rosuvastatin Effect 2017", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_84", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Randomized Comparison of Efficacy 2026", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_85", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "STATIC Statin Termination 2026", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_86", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Atorvastatin for Reduction of Day 2021", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_87", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Changes in Plaque Characteristics 2026", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_88", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Effect of Pravastatin in the Subjects 2017", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_89", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Evaluate the Efficacy and Safety 2026", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_90", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "MACE 2026", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_91", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Rosuvastatin for Prevention of Anthracycline-induced n.d.", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_92", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Simvastatin Addition for Patients 2019", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_93", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Statin Monotherapy or Statins 2021", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_94", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "APICES n.d.", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_95", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Carvedilol Simvastatin vs Carvedilol n.d.", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_96", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Comparison of Pitavastatin Plus n.d.", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_97", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Does Rosuvastatin Delay 2018", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_98", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Effects of Atorvastatin in Graves' 2021", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_99", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Intermediate-dose vs Standard Prophylactic 2021", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_100", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Moderate-intensity Statin vs Individualized n.d.", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_101", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Pravastatin Intervention to Delay 2018", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_102", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Pravastatin to Prevent Preeclampsia 2021", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_103", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Statin Monotherapy for Treatment 2022", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_104", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Statin Reminders for Improving 2024", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_105", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "StAtins for Venous Event 2020", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_106", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Effects of Rosuvastatin on Running 2026", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_107", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Ursodeoxycholic Acid Attenuates 2026", "type": "source", "url": null, "year": null}], "publication_id": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "screening": {"excluded": 0, "exclusion_reasons": ["No PRISMA full-text exclusion-stage filter was applied."], "flow": ["identified", "screened", "excluded_with_reasons", "included"], "identified": 62, "included": 62, "included_or_retained": 62, "screened": 62, "wording": "62 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit."}}

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "f1b39b71-2cc3-43a3-ab5a-287574699c7d",
  "researka_submission_id": "7c330c3f-54b5-4c2a-b35b-92a340d75e52",
  "sidecar_name": "claim_graph.json",
  "sidecar_url": "https://api.researka.org/publications/f1b39b71-2cc3-43a3-ab5a-287574699c7d/sidecars/claim_graph.json"
}